Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

This is not a financial advice!

Be carful before entering Monday is ER coming.

Upcoming catalyst in 2H 2024

Block buy recently

Rel. Vol. on 03/15/2024 at 3.9

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Keep an eye on 0.85/ 1.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 0.15

TP approx. 1.5

Most info on the chart.

Trade carefully!
Note
nice lil spike
Note
another spike to 0.5 in post market
Trade closed: stop reached
Chart PatternsFundamental AnalysisTrend Analysis

Disclaimer